Read one actual disclosure before using it
Scroll sideways to compare all columns. Select a heading to sort.
| 2026-05-22 | 2026-05-19 | PHAT | A | 24,122 | Not reported |
No matching rows. Clear the filter to see all records.
First displayed source row from Recent SEC transactions. The full bounded history and coverage notes remain below.
The displayed observation date is 2026-05-19 and its public availability date is 2026-05-22. Subtracting those calendar dates gives 3 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.
This row is code A: a award. An award is an acquisition but is not an open-market purchase. A purchase-following rule must not count it as code P.
Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.
Issuer relationships
Inspect all 21 displayed rows: Issuer relationships
A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.
Scroll sideways to compare all columns. Select a heading to sort.
| LA JOLLA PHARMACEUTICAL CO | 0000920465 | LJPC | No | Yes |
| AMICUS THERAPEUTICS INC | 0001178879 | FOLD | No | Yes |
| PORTOLA PHARMACEUTICALS INC | 0001269021 | PTLA | No | Yes |
| COLLEGIUM PHARMACEUTICAL, INC | 0001267565 | COLL | No | No |
| GLAUKOS Corp | 0001192448 | GKOS | No | No |
| Sierra Oncology, Inc. | 0001290149 | DNAI, SRRA | No | Yes |
| ANAPTYSBIO, INC | 0001370053 | ANAB | No | Yes |
| ALPINE IMMUNE SCIENCES, INC. | 0001626199 | ALPN | No | Yes |
| Allena Pharmaceuticals, Inc. | 0001624658 | ALNA | No | Yes |
| Aptinyx Inc. | 0001674365 | APTX | No | Yes |
| Entasis Therapeutics Holdings Inc. | 0001724344 | ETTX | No | Yes |
| Mirum Pharmaceuticals, Inc. | 0001759425 | MIRM | No | No |
| Phathom Pharmaceuticals, Inc. | 0001783183 | PHAT | No | Yes |
| Arcutis Biotherapeutics, Inc. | 0001787306 | ARQT | No | No |
| Passage BIO, Inc. | 0001787297 | PASG | No | No |
| Tarsus Pharmaceuticals, Inc. | 0001819790 | TARS | No | No |
| Frazier Lifesciences Acquisition Corp | 0001828326 | FLAC | Yes | Yes |
| HilleVax, Inc. | 0001888012 | HLVX | No | No |
| NewAmsterdam Pharma Co N.V. | 0001936258 | NAMS | No | Yes |
| MBX Biosciences, Inc. | 0001776111 | MBX | No | No |
| Attovia Therapeutics, Inc. | 0002058707 | ATTO | No | Yes |
No matching rows. Clear the filter to see all records.
Recent SEC transactions
Inspect all 18 displayed rows: Recent SEC transactions
Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.
Scroll sideways to compare all columns. Select a heading to sort.
| 2026-05-22 | 2026-05-19 | PHAT | A | 24,122 | Not reported |
| 2025-10-01 | 2025-09-26 | MBX | P | 666,666 | Not reported |
| 2025-09-18 | 2025-09-15 | NAMS | P | 660 | Not reported |
| 2025-09-11 | 2025-09-08 | NAMS | P | 1,260 | Not reported |
| 2025-08-14 | 2025-08-11 | NAMS | P | 471 | Not reported |
| 2025-06-27 | 2025-06-25 | NAMS | P | 1,260 | Not reported |
| 2025-06-27 | 2025-06-24 | NAMS | P | 2,520 | Not reported |
| 2025-06-19 | 2025-06-16 | NAMS | P | 8,584 | Not reported |
| 2025-06-06 | 2025-06-03 | PHAT | A | 10,500 | Not reported |
| 2025-06-06 | 2025-06-03 | PHAT | A | 17,500 | Not reported |
| 2025-05-24 | 2025-05-21 | PHAT | P | 3,780 | Not reported |
| 2025-05-16 | 2025-05-14 | PHAT | P | 6,300 | Not reported |
| 2025-05-16 | 2025-05-13 | PHAT | P | 1,120 | Not reported |
| 2025-05-14 | 2025-05-12 | PHAT | P | 12,601 | Not reported |
| 2025-05-14 | 2025-05-09 | PHAT | P | 2,226 | Not reported |
| 2025-05-14 | 2025-05-09 | PHAT | P | 33,376 | Not reported |
| 2025-03-29 | 2025-03-26 | NAMS | P | 1,135 | Not reported |
| 2025-03-07 | 2025-03-04 | NAMS | P | 4,005 | Not reported |
No matching rows. Clear the filter to see all records.
Up to 50 transactions from the recent two-year owner window.
Source evidence and strategy eligibility
The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.
The current directory marks this owner's filing coverage verified.